Trademark Overview
On Wednesday, February 5, 2025, a trademark application was filed for UNDERSTUDIED RESEARCH INITIATIVE with the United States Patent and Trademark Office. The USPTO has given the UNDERSTUDIED RESEARCH INITIATIVE trademark a serial number of 99030020. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 5, 2025. This trademark is owned by Global Alzheimer's Platform Foundation Inc.. The UNDERSTUDIED RESEARCH INITIATIVE trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Promoting public awareness of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases and issues related thereto in the nature of patient registries, patient research, patient advocacy and patient fundraising efforts; Promoting public awareness of health care issues for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases, and the importance of patient registration on Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease registries; Charitable services, namely, organizing and developing programs that aim to improve the lives of patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Charitable business services, namely, administration of programs for enabling participants to receive services for Alzheimer's, neurodegenerative diseases and other n...
Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer's, neuro degenerative diseases and other neurological and central nervous system diseases; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Providing medical and scientific research information in the field of clinical trials
